市場調査レポート
商品コード
1073034

電気生理学的アブレーションカテーテルパイプラインレポート(2022年更新版):開発段階、セグメント、地域と国、規制パス、主要企業など

Electrophysiology Ablation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

出版日: | 発行: GlobalData | ページ情報: 英文 122 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
電気生理学的アブレーションカテーテルパイプラインレポート(2022年更新版):開発段階、セグメント、地域と国、規制パス、主要企業など
出版日: 2022年03月30日
発行: GlobalData
ページ情報: 英文 122 Pages
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、電気生理学的アブレーションカテーテルのパイプライン製品に関する総合情報を、各開発段階の製品の比較分析と進行中の臨床試験に関する情報とともに提供しています。レポートは開発中の電気生理学的アブレーションカテーテルを広範にカバーし、主要パイプライン製品の詳細(製品説明、ライセンスおよび提携の詳細、その他の開発活動など)の概観、開発に携わる主要企業の概観とそのすべてのパイプラインプロジェクトのリスト、パイプライン製品に特化した進行中の主要な臨床試験データ、セグメント/業界における最近の開発状況などを含み、包括的な情報を提供しています。

目次

第1章 目次

  • 表のリスト
  • 図のリスト

第2章 イントロダクション

  • 電気生理学的アブレーションカテーテルの概要

第3章 開発中の製品

  • 開発段階別のパイプライン製品
  • セグメント別のパイプライン製品
  • 地域別のパイプライン製品
  • 規制パス別のパイプライン製品
  • 承認予定日までのパイプライン製品
  • 進行中の臨床試験

第4章 電気生理学的アブレーションカテーテル:企業が開発中のパイプライン製品

  • 電気生理学的アブレーションカテーテル企業:開発段階別のパイプライン製品
  • 開発段階別のパイプライン製品

第5章 電気生理学的アブレーションカテーテル:企業と製品概要

  • Ablacon Inc
  • Acotec Scientific Co Ltd
  • Apama Medical Inc
  • APT Medical Inc
  • Biosense Webster Inc
  • BioTex Inc
  • Boston Scientific Corp
  • CardioFocus Inc
  • CardioNova Ltd
  • CathEffects LLC
  • CathRx Ltd
  • Cibiem, Inc.
  • Columbia University
  • Cordis Corp
  • CoreMap Inc
  • CryoTherapeutics Gmbh
  • Epicardial Technologies Inc(休止中)
  • Ethicon US LLC
  • Eximo Medical Ltd
  • FocusStart LLC
  • Hansen Medical Inc(休止中)
  • Hyblate Medical
  • Imricor Medical Systems Inc
  • Interventional Imaging, Inc.
  • Iowa Approach Inc.
  • Maestro Heart SA
  • Medlumics SL
  • Medtronic Plc
  • MedWaves Inc
  • MicroPort Scientific Corp
  • Northwestern University
  • Novasentis Inc
  • S4 Medical Corp
  • SCR, Inc.
  • Seattle Children's Hospital
  • Shanghai HeartCare Medical Technology Co Ltd
  • Shanghai MicroPort EP MedTech Co Ltd
  • St. Jude Medical LLC
  • Stereotaxis Inc
  • University of Arkansas at Little Rock
  • University of Michigan
  • University of Rochester
  • University of Texas Medical Branch at Galveston
  • Vanderbilt University
  • Vimecon GmbH
  • Vivonics Inc
  • Voyage Medical(休止中)
  • Zylox-Tonbridge Medical Technology Co Ltd

第6章 電気生理学的アブレーションカテーテル:最近の開発

  • 2022年3月9日:Stereotaxisがセントルイスに新しい世界本社をグランドオープンすると発表
  • 2022年1月28日:Japan Lifeline Co.が2021年12月31日までの9ヶ月間の連結決算発表
  • 2022年1月4日:Medtronicの会長兼CEOのGeoff MarthaがJ.P. Morganヘルスケアカンファレンスで講演
  • 2021年12月9日:CordisがGeorge Adams博士を最高医療責任者に任命
  • 2021年11月18日:MicroPort RehabTech TherMotion Cryo-Thermo圧縮装置が中国での販売を承認
  • 2021年11月8日:Boston Scientificが今後の会議スケジュールを発表
  • 2021年11月2日:CordisがMuscariを南北アメリカのプレジデントに任命
  • 2021年11月1日:Japan Lifelineが2022年度第2四半期決算を発表
  • 2021年10月28日:Stereotaxisが2021年11月11日の2021年第3四半期の財務結果を報告
  • 2021年10月27日:Boston Scientificが2021年第3四半期の結果を発表
  • 2021年10月7日:28万平方メートルのMicroPort MegaFactoryと世界の医療体験センターの建設が開始
  • 2021年9月9日:Boston Scientificが2021年の投資家デー会議を発表
  • 2021年8月4日:Japan Lifelineが2022年度第1四半期決算を発表
  • 2021年7月26日:StereotaxisがMyriam J. Curet医学博士の任命により取締役会を強化
  • 2021年7月20日:Stereotaxisが2021年8月10日の2021年第2四半期の財務結果を報告
  • 2021年6月25日:Japan Lifeline第41回定時株主総会決議通知
  • 2021年6月24日:PeterArduiniがGE healthcareのCEOに任命
  • 2021年5月24日:Boston ScientificがBernsteinの第37回年次戦略的決定会議に参加
  • 2021年5月17日:MicroPort Orthopedicsが日中友好病院と関節手術に関する合同ワークショップを開催

第7章 付録

  • 調査手法
  • GlobalDataについて
  • カスタマーサービス
  • 免責事項
図表

List of Tables

List of Tables

  • Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
  • Electrophysiology Ablation Catheters - Pipeline Products by Segment
  • Electrophysiology Ablation Catheters - Pipeline Products by Territory
  • Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path
  • Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date
  • Electrophysiology Ablation Catheters - Ongoing Clinical Trials
  • Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development
  • Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
  • Electrophysiology Ablation Catheters - Pipeline Products by Segment
  • Electrophysiology Ablation Catheters - Pipeline Products by Territory
  • Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path
  • Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date
  • Electrophysiology Ablation Catheters - Ongoing Clinical Trials
目次
Product Code: GDME1324EPD

GlobalData's Medical Devices sector report, "Electrophysiology Ablation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Electrophysiology Ablation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An electrophysiology ablation catheter contains an electrode on one end which emits RF waves to destroy a small area of heart tissue in the abnormal conduction pathway, blocking further channeling of the impulses causing the heart's abnormal rhythm.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Electrophysiology Ablation Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Electrophysiology Ablation Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Electrophysiology Ablation Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Electrophysiology Ablation Catheters Overview

3 Products under Development

  • 3.1 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
  • 3.2 Electrophysiology Ablation Catheters - Pipeline Products by Segment
  • 3.3 Electrophysiology Ablation Catheters - Pipeline Products by Territory
  • 3.4 Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path
  • 3.5 Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date
  • 3.6 Electrophysiology Ablation Catheters - Ongoing Clinical Trials

4 Electrophysiology Ablation Catheters - Pipeline Products under Development by Companies

  • 4.1 Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development
  • 4.2 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development

5 Electrophysiology Ablation Catheters Companies and Product Overview

  • 5.1 Ablacon Inc Company Overview
  • 5.2 Acotec Scientific Co Ltd Company Overview
  • 5.3 Apama Medical Inc Company Overview
  • 5.4 APT Medical Inc Company Overview
  • 5.5 Biosense Webster Inc Company Overview
  • 5.6 BioTex Inc Company Overview
  • 5.7 Boston Scientific Corp Company Overview
  • 5.8 CardioFocus Inc Company Overview
  • 5.9 CardioNova Ltd Company Overview
  • 5.10 CathEffects LLC Company Overview
  • 5.11 CathRx Ltd Company Overview
  • 5.12 Cibiem, Inc. Company Overview
  • 5.13 Columbia University Company Overview
  • 5.14 Cordis Corp Company Overview
  • 5.15 CoreMap Inc Company Overview
  • 5.16 CryoTherapeutics Gmbh Company Overview
  • 5.17 Epicardial Technologies Inc (Inactive) Company Overview
  • 5.18 Ethicon US LLC Company Overview
  • 5.19 Eximo Medical Ltd Company Overview
  • 5.20 FocusStart LLC Company Overview
  • 5.21 Hansen Medical Inc (Inactive) Company Overview
  • 5.22 Hyblate Medical Company Overview
  • 5.23 Imricor Medical Systems Inc Company Overview
  • 5.24 Interventional Imaging, Inc. Company Overview
  • 5.25 Iowa Approach Inc. Company Overview
  • 5.26 Maestro Heart SA Company Overview
  • 5.27 Medlumics SL Company Overview
  • 5.28 Medtronic Plc Company Overview
  • 5.29 MedWaves Inc Company Overview
  • 5.30 MicroPort Scientific Corp Company Overview
  • 5.31 Northwestern University Company Overview
  • 5.32 Novasentis Inc Company Overview
  • 5.33 S4 Medical Corp Company Overview
  • 5.34 SCR, Inc. Company Overview
  • 5.35 Seattle Children's Hospital Company Overview
  • 5.36 Shanghai HeartCare Medical Technology Co Ltd Company Overview
  • 5.37 Shanghai MicroPort EP MedTech Co Ltd Company Overview
  • 5.38 St. Jude Medical LLC Company Overview
  • 5.39 Stereotaxis Inc Company Overview
  • 5.40 University of Arkansas at Little Rock Company Overview
  • 5.41 University of Michigan Company Overview
  • 5.42 University of Rochester Company Overview
  • 5.43 University of Texas Medical Branch at Galveston Company Overview
  • 5.44 Vanderbilt University Company Overview
  • 5.45 Vimecon GmbH Company Overview
  • 5.46 Vivonics Inc Company Overview
  • 5.47 Voyage Medical (Inactive) Company Overview
  • 5.48 Zylox-Tonbridge Medical Technology Co Ltd Company Overview

6 Electrophysiology Ablation Catheters- Recent Developments

  • 6.1 Mar 09, 2022: Stereotaxis Announces Grand Opening of New Global Headquarters in St. Louis
  • 6.2 Jan 28, 2022: Japan Lifeline Co. Announces Consolidated Financial Results for the Nine months Ended December 31, 2021
  • 6.3 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
  • 6.4 Dec 09, 2021: Cordis appoints Dr. George Adams to Chief Medical Officer
  • 6.5 Nov 18, 2021: MicroPort RehabTech TherMotion Cryo-Thermo compression device approved for marketing in China
  • 6.6 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
  • 6.7 Nov 02, 2021: Cordis Names Muscari President Of The Americas
  • 6.8 Nov 01, 2021: Japan Lifeline Announces FY3/2022 2Q Financial Results
  • 6.9 Oct 28, 2021: Stereotaxis to Report Third Quarter 2021 Financial Results on November 11, 2021
  • 6.10 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
  • 6.11 Oct 07, 2021: Construction begins on 280,000-square-meter MicroPort MegaFactory and global medical experience center
  • 6.12 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
  • 6.13 Aug 04, 2021: Japan Lifeline Announces FY3/2022 1Q Financial Results
  • 6.14 Jul 26, 2021: Stereotaxis Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.
  • 6.15 Jul 20, 2021: Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021
  • 6.16 Jun 25, 2021: Japan Lifeline Notice of Resolution of the 41st Annual General Meeting of Shareholders
  • 6.17 Jun 24, 2021: Peter Arduini named CEO of GE healthcare
  • 6.18 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
  • 6.19 May 17, 2021: MicroPort Orthopedics holds joint workshop on joint surgery with China-Japan Friendship Hospital

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer